2m 2m 2m 2m 2m 2m 2m
Gilead Sciences (GILD)
NASDAQ
$143.94+$0.22 (+0.15%)
Price as of Sep 11, 2026 7:30 PM EDT- $179.6BMarket Cap
- 28.73%1-Year Change
- Drug Manufacturers - GeneralIndustry
Gilead Sciences (GILD)
$143.94+$0.22 (+0.15%)
GILD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $143.72 | ||
Change | -$1.09 (-0.75%) | ||
Open | $145.24 | ||
High | $145.99 | ||
Low | $143.50 | ||
Previous Close | $144.81 | ||
Volume | 4,216,027 | ||
30-Day Average Volume | 5,272,769 | ||
1-Week Change | -4.82% | ||
1-Month Change | 5.86% | ||
1-Year Change | 28.73% | ||
3-Year Change | 105.90% | ||
5-Year Change | 142.98% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $49.4B | ||
Market Cap | $179.6B | ||
Enterprise Value | $202.6B | ||
Period: QTR TTM FY | |||
Revenue | $7.6B | ||
Net Income | -$10.5B | ||
Free Cash Flow | $3.4B | ||
EBIT | -$10.3B | ||
EBITDA | -$10.2B | ||
Net Working Capital | $2.9B | ||
EPS | -$8.45 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | 27 | ||
P/B | 15 | ||
P/E | -17 | ||
PEG | 0 | ||
Price/Free Cash Flow | 52 | ||
Price/Operating Cash Flow | 50 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.28% | ||
Trailing Annual Dividend Yield | 2.24% | ||
Ex-Dividend Date | 09/15/2026 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 01/28/2013 | ||
Earnings & Revenue
Annual Dividend Yield